| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-15 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |